As of 2025-05-20, the Relative Valuation of Apyx Medical Corp (APYX) is (18.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.49 USD, the upside of Apyx Medical Corp based on Relative Valuation is -1353.5%.
The range of the Relative Valuation is (18.53) - (19.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.9x - 43.5x | 36.6x |
| Forward P/E multiples | 33.1x - 37.1x | 33.8x |
| Fair Price | (18.53) - (19.66) | (18.68) |
| Upside | -1343.3% - -1419.5% | -1353.5% |
| Date | P/E |
| 2025-05-16 | -2.70 |
| 2025-05-15 | -2.79 |
| 2025-05-14 | -2.66 |
| 2025-05-13 | -2.98 |
| 2025-05-12 | -2.08 |
| 2025-05-09 | -2.19 |
| 2025-05-08 | -2.23 |
| 2025-05-07 | -2.36 |
| 2025-05-06 | -2.02 |
| 2025-05-05 | -2.19 |
| 2025-05-02 | -2.36 |
| 2025-05-01 | -2.02 |
| 2025-04-30 | -1.96 |
| 2025-04-29 | -1.77 |
| 2025-04-28 | -1.70 |
| 2025-04-25 | -1.68 |
| 2025-04-24 | -1.72 |
| 2025-04-23 | -1.70 |
| 2025-04-22 | -1.78 |
| 2025-04-21 | -1.85 |
| 2025-04-17 | -1.84 |
| 2025-04-16 | -1.75 |
| 2025-04-15 | -1.92 |
| 2025-04-14 | -2.02 |
| 2025-04-11 | -1.81 |
| 2025-04-10 | -1.66 |
| 2025-04-09 | -1.70 |
| 2025-04-08 | -1.64 |
| 2025-04-07 | -1.89 |
| 2025-04-04 | -1.87 |
| 2025-04-03 | -2.19 |
| 2025-04-02 | -2.32 |
| 2025-04-01 | -2.36 |
| 2025-03-31 | -2.58 |
| 2025-03-28 | -2.45 |
| 2025-03-27 | -2.47 |
| 2025-03-26 | -2.40 |
| 2025-03-25 | -2.56 |
| 2025-03-24 | -2.60 |
| 2025-03-21 | -2.38 |
| 2025-03-20 | -2.19 |
| 2025-03-19 | -2.06 |
| 2025-03-18 | -2.02 |
| 2025-03-17 | -2.13 |
| 2025-03-14 | -1.89 |
| 2025-03-13 | -1.96 |
| 2025-03-12 | -2.02 |
| 2025-03-11 | -2.01 |
| 2025-03-10 | -2.11 |
| 2025-03-07 | -2.24 |